HU9202821D0 - Method for cloning and producing polypeptides constituting glycoprotein ib binding domain of human von willebrand factor - Google Patents

Method for cloning and producing polypeptides constituting glycoprotein ib binding domain of human von willebrand factor

Info

Publication number
HU9202821D0
HU9202821D0 HU922821A HU282192A HU9202821D0 HU 9202821 D0 HU9202821 D0 HU 9202821D0 HU 922821 A HU922821 A HU 922821A HU 282192 A HU282192 A HU 282192A HU 9202821 D0 HU9202821 D0 HU 9202821D0
Authority
HU
Hungary
Prior art keywords
glycoprotein
cloning
binding domain
von willebrand
willebrand factor
Prior art date
Application number
HU922821A
Other languages
Hungarian (hu)
Other versions
HUT63183A (en
HU216066B (en
Inventor
Leonard Garfinkel
Tamar Richter
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of HU9202821D0 publication Critical patent/HU9202821D0/en
Publication of HUT63183A publication Critical patent/HUT63183A/en
Publication of HU216066B publication Critical patent/HU216066B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HUP9202821A 1990-03-02 1991-03-01 Process for producing polypeptides comprising von willebrand factor gpib binding domain and pharmaceutical preparations containing same HU216066B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48776790A 1990-03-02 1990-03-02

Publications (3)

Publication Number Publication Date
HU9202821D0 true HU9202821D0 (en) 1992-11-30
HUT63183A HUT63183A (en) 1993-07-28
HU216066B HU216066B (en) 1999-04-28

Family

ID=23937035

Family Applications (1)

Application Number Title Priority Date Filing Date
HUP9202821A HU216066B (en) 1990-03-02 1991-03-01 Process for producing polypeptides comprising von willebrand factor gpib binding domain and pharmaceutical preparations containing same

Country Status (10)

Country Link
EP (1) EP0517826A4 (en)
JP (1) JPH05506646A (en)
CA (1) CA2077446A1 (en)
FI (1) FI923935A (en)
HU (1) HU216066B (en)
IL (1) IL97399A0 (en)
NO (1) NO923410L (en)
NZ (1) NZ237244A (en)
RU (1) RU2109816C1 (en)
WO (1) WO1991013093A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900476A (en) * 1986-05-30 1999-05-04 The Scripps Research Institute Therapeutic domains of van Willebrand factor
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
FR2686901A1 (en) * 1992-01-31 1993-08-06 Rhone Poulenc Rorer Sa NOVEL ANTITHROMBOTIC POLYPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
WO1994018225A1 (en) * 1993-02-11 1994-08-18 The Du Pont Merck Pharmaceutical Company 15-oxasterols as hypocholesterolemics
ZA942818B (en) * 1993-04-23 1995-01-30 Bio Technology General Corp Method of enhancing thrombolysis.
AT405403B (en) 1997-02-27 1999-08-25 Immuno Ag CLEANING OF WILLEBRAND FACTOR BY CATION EXCHANGER CHROMATOGRAPHY
AT406373B (en) 1997-02-27 2000-04-25 Immuno Ag METHOD FOR CLEANING FACTOR VIII / VWF COMPLEX BY CATION EXCHANGER CHROMATOGRAPHY
AT408443B (en) * 1998-02-27 2001-11-26 Immuno Ag METHOD FOR OBTAINING PURIFIED FACTOR VIII: C / VWF COMPLEX
US6605222B1 (en) * 1998-05-20 2003-08-12 Baxter Aktiengesellschaft Method for producing a factor VIII/von Willebrand factor complex
DE102007031708A1 (en) 2007-07-06 2009-01-08 Dade Behring Marburg Gmbh Determination of von Willebrand factor activity in the absence of ristocetin
CN102459599A (en) * 2009-06-03 2012-05-16 雷加多生物科学公司 Nucleic acid modulators of glycoprotein vi
GB201707139D0 (en) * 2017-05-04 2017-06-21 Imp Innovations Ltd Polypeptides
CN110624105B (en) * 2019-09-24 2021-06-11 苏州大学 Sequences of structurally sensitive polypeptide antigens of von Willebrand factor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74909A (en) * 1984-04-20 1992-01-15 Genentech Inc Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
DE3751179T2 (en) * 1986-05-30 1995-07-27 Scripps Research Inst Peptides that inhibit the binding of the Von Willebrand factor.

Also Published As

Publication number Publication date
FI923935A0 (en) 1992-09-02
RU2109816C1 (en) 1998-04-27
NO923410D0 (en) 1992-09-01
AU7496491A (en) 1991-09-18
WO1991013093A1 (en) 1991-09-05
HUT63183A (en) 1993-07-28
HU216066B (en) 1999-04-28
AU645077B2 (en) 1994-01-06
NZ237244A (en) 1992-10-28
FI923935A (en) 1992-09-02
JPH05506646A (en) 1993-09-30
EP0517826A4 (en) 1993-05-26
NO923410L (en) 1992-10-26
CA2077446A1 (en) 1991-09-03
EP0517826A1 (en) 1992-12-16
IL97399A0 (en) 1992-06-21

Similar Documents

Publication Publication Date Title
GB2273109B (en) Composite metalising wire and method of using
EP0455185A3 (en) Hair-treating microemulsion composition and method of preparing and using the same
DE69214709D1 (en) New antibodies and methods of using them
EP0478166A3 (en) Composite weldable stud and method of using same
GB9322628D0 (en) Microencapsualted adhesive composition and method of making same
IL104007A0 (en) Adhesive composition and method of using it
GB9009549D0 (en) Recombinant antibody and method
HU9202821D0 (en) Method for cloning and producing polypeptides constituting glycoprotein ib binding domain of human von willebrand factor
DE59302386D1 (en) USE OF POLYCONDENSATE AND NEW POLYCONDENSATE
EP0438312A3 (en) Recombinant human anti-cd18 antibodies
EP0440351A3 (en) Recombinant human anti-cd18 antibodies
EP0513796A3 (en) Composite structure and method of making
IL88308A0 (en) Peptides that block the binding of von willebrand factor
GB2255262B (en) Electric heater and method of making same
DE69232097D1 (en) C-TERMINAL PEPTIDE SEQUENCING USING DIPHENYLPHOSPHOROISOTHIOCYANIDATE AND PYRIDINE
EP0446844A3 (en) Cycloconverter and the method of controlling the same
EP0478366A3 (en) Recombinant hybrid immunoglobulin molecules and method of use
NO951926D0 (en) Process for Preparation of Recombinant Aprotinin and Recombinant Aprotinin Variants with Natural N-Terminal Sequence
HUP9903789A3 (en) Von willebrand factor derivative and method for isolating proteins
AU9069591A (en) Therapeutic fragments of von willebrand factor
EP0542843A4 (en) Cloning and expression of toxoplasma antigens and use of recombinant antigens
EP0459788A3 (en) Modified proteins and methods of producing same
EP0451211A4 (en) Cloning and production of polypeptide analogs of human fibronectin and method of using such polypeptide analogs
EP0469364A3 (en) Method of forming and stressing composite springs
HUP9904137A3 (en) Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee